<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Articles SYSTEM "HBI_DTD">
<Articles><Article><Journal><PublisherName></PublisherName><JournalTitle>International Journal of Preventive Medicine (Int J Prev Med)</JournalTitle><Issn>2008-7802</Issn><Volume>3</Volume><Issue>4</Issue><PubDate PubStatus="epublish"><Year>2012</Year><Month>03</Month><Day>27</Day></PubDate></Journal><title locale="en_US">Vitamin B12 Deficiency and Multiple Sclerosis; Is there Any Association?</title><FirstPage>595</FirstPage><LastPage>595</LastPage><Language>EN</Language><AuthorList><Author><affiliation locale="en_US">Department of Neurology and Isfahan Neuroscience Research Center, Isfahan, Iran</affiliation></Author><Author><affiliation locale="en_US">Department of Neurology and Isfahan Neuroscience Research Center, Isfahan, Iran</affiliation></Author><Author><affiliation locale="en_US">Medical Students’ Research Center, Isfahan University of Medical Sciences, Isfahan, Iran</affiliation></Author><Author><affiliation locale="en_US">Medical Students’ Research Center, Isfahan University of Medical Sciences, Poursina Hakim Research Institution, Isfahan, Iran</affiliation></Author></AuthorList><History><PubDate PubStatus="received"><Year>2012</Year><Month>03</Month><Day>27</Day></PubDate></History><abstract locale="en_US">&lt;strong&gt;Background:&lt;/strong&gt; Vitamin B12 (Cobalamin) deficiency can result in&lt;br /&gt;some clinical and paraclinical characteristics similar to what is seen in multiple sclerosis (MS) patients. This study aimed to evaluate the controversial association between vitamin B12 deficiency and MS.&lt;br /&gt;&lt;strong&gt;Methods:&lt;/strong&gt; We measured serum vitamin B12 in 60 patients with&lt;br /&gt;MS and 38 healthy controls. Clinical disability was evaluated&lt;br /&gt;according to the Extended Disability Status Scale (EDSS). Serum&lt;br /&gt;B12 concentration was measured with Radioimmunoassay Dual&lt;br /&gt;Isotope method. The cutoff value for low serum vitamin B12&lt;br /&gt;concentrations was 75 pg/mL. Patients were in remission at the&lt;br /&gt;time of blood draw.&lt;br /&gt;&lt;strong&gt;Results:&lt;/strong&gt; There were 13 (21.6%) MS patients and 10 (26.3%)&lt;br /&gt;controls with low serum B12 concentration with no significant&lt;br /&gt;difference between the groups; P&amp;gt;0.05. The mean serum vitamin B12 concentration in MS patients (108.9&amp;plusmn;45.3 pg/mL) was not significantly different compared with controls (98.9&amp;plusmn;44.4 pg/mL); P=0.284. Likewise, there was no correlation between the&lt;br /&gt;concentration of serum vitamin B12 and disease&amp;rsquo; age of onset,&lt;br /&gt;duration, subtypes, or disability status.&lt;br /&gt;&lt;strong&gt;Conclusions:&lt;/strong&gt; In contrast to some previous reports, our findings&lt;br /&gt;did not support any association between B12 deficiency and MS.&lt;br /&gt;&lt;strong&gt;Keywords:&lt;/strong&gt; Cobalamin, multiple sclerosis, vitamin B12</abstract><web_url>http://ijpm.mui.ac.ir/index.php/ijpm/article/view/595</web_url><pdf_url>http://ijpm.mui.ac.ir/index.php/ijpm/article/download/595/447</pdf_url></Article></Articles>
